CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Assess response to pembrolizumab in both primary tumor, normal breast stroma, circulating lymphocytes and serum exosomes in treatme ...
Phase 1
Atlanta, Georgia, United States and 2 other locations
This research is to evaluate the effectiveness of Talazoparib as a potential treatment for metastatic breast cancer with a BRCA 1 o...
Phase 2
Atlanta, Georgia, United States and 6 other locations
monotherapy vs. SOC chemotherapy combined with tocilizumab in in Black and non-Black patients with metastatic triple negative or ER low breast...
Phase 2
Atlanta, Georgia, United States and 4 other locations
therapy as a treatment after surgery for hormone receptor positive breast cancer.The study drugs involved in this study are:* A com...
Phase 2
Atlanta, Georgia, United States and 31 other locations
breast biopsy occurs if biopsy is needed....
Dacula, Georgia, United States and 3 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Atlanta, Georgia, United States and 76 other locations
A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive ...
Phase 2
Atlanta, Georgia, United States and 18 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Atlanta, Georgia, United States and 106 other locations
A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...
Phase 2
Atlanta, Georgia, United States and 63 other locations
This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...
Phase 3
Atlanta, Georgia, United States and 226 other locations
Clinical trials
Research sites
Resources
Legal